Eicosapentaenoic acid inhibits tube formation of vascular endothelial cellsin vitro
Tóm tắt
We previously have described a quantitative angiogenesisin vitro model, in which endothelial cells are cultured between two layers of type I collagen gel and become organized into tube-like structures. Using this model, the effect of eicosapentaenoic acid (20∶5n−3) on tube formation was investigated. When the endothelial cells isolated from bovine carotid artery were treated for 2 days with 5 μg/mL of arachidonic acid (20∶4n−6), eicosapentaenoic acid or docosahexaenoic acid (22∶6n−3), these polyunsaturated fatty acids were extensively incorporated into cellular phospholipids. The content of arachidonic, eicosapentaenoic and docosahexaenoic acid increased from 9.58% to 23.29%, from 0.98% to 11.76% and from 6.88% to 18.40%, respectively. When the eicosapentaenoic acid-treated cells were cultured between collagen gels, the tube-forming ability of the cells was markedly inhibited. The inhibition was dose-dependent between 1.0 and 5.0 μg/mL of eicosapentaenoic acid. At 5.0 μg/mL of eicosapentaenoic acid the inhibition reached 76%. By contrast, arachidonic acid increased tube formation, and docosahexaenoic acid had no effect. To elucidate the mechanism of eicosapentaenoic acid induced inhibition ofin vitro tube formation, we examined the effect of the acid on the proliferation of endothelial cells. Eicosapentaenoic acid at any dose (<5.0 μg/mL) had no effect on the proliferation of endothelial cells cultured on plastic plates without collagen gel. However, when the cells were cultured between collagen gels, eicosapentaenoic acid inhibited cell growth in a dose-dependent manner with maximum inhibition being observed at 2.5 μg/mL. These data suggest that eicosapentaenoic acid suppresses tube formation of endothelial cells, at least in part,via its inhibitory effect on cellular proliferation. Thus eicosapentaenoic acid may act as an endogenous inhibitor of angiogenesis under various pathological conditions, including tumor growth and chronic inflammation.
Tài liệu tham khảo
Folkman, J. (1985)Adv. Cancer Res. 43, 175–203.
D'Amore, P.A., and Braunhat, S.J. (1988) inEndothelial Cells (Ryan, U.S., ed.) Vol. 2, pp. 13–37, CRC Press, Boca Raton.
Taylor, S., and Folkman, J. (1982)Nature 297, 307–312.
Crum, R., Szabo, S., and Folkman, J. (1985)Science 230, 1375–1378.
Folkman, J., Weisz, P.B., Joullie, M.M., Li, W.W., and Ewing, W.R. (1989)Science 243, 1490–1493.
Rastinejad, F., Polverini, P.J., and Bouck, N.P. (1989)Cell 56, 345–355.
Shimokawa, H., Lam, J.Y.T., Chesebro, J.H., Bowie, E.J.W., and Vanhoutte, P.M. (1987)Circulation 76, 898–905.
Fox, P.L., and DiCorleto, P.E. (1988)Science 241, 453–456.
Morita, I., Kanayasu, T., and Murota, S. (1984)Biochim. Biophys. Acta 792, 304–309.
Kanayasu, T., Nakao-Hayashi, J., Asuwa, N., Morita, I., Ishii, T., Ito, H., and Murota, S. (1989)Biochem. Biophys. Res. Commun. 159, 572–578.
Suzuki, Y., Morita, I., Ishizaki, Y., Aamane, Y., and Murota, S. (1989)Biochim. Biophys. Acta 1012, 135–139.
Bligh, E.G., and Dyer, W.J. (1959)Can. J. Biochem. Physiol. 37, 911–917.
Ohtsu, A., Fujii, K., and Kurozumi, S. (1988)Prostaglandins Leukotrienes and Essential Fatty Acids 33, 35–39.
Form, D.M., and Auerbach, R. (1983)Proc. Exp. Biol. Med. 172, 214–218.
Matsubara, T., Saura, R., Hirohata, K., and Ziff, M. (1989)J. Clin. Invest. 83, 158–167.
Matsubara, T., and Ziff, M. (1987)J. Clin. Invest. 79, 1440–1446.
Kremer, J.M., Jubiz, W., Michaleck, A., Rynes, R.I., Bartholomew, L.E., Bigaouette, J., Timchalk, M., Beeler, D., and Lininger, L. (1987)Annals Int. Med. 106, 497–503.
Karmali, R.A., Marsh, J., and Fuchs, C. (1984)J. Natl. Cancer Inst. 73, 457–461.
Madri, J.A., Pratt, B.M., and Tucker, A.M. (1988)J. Cell Biol. 106, 1375–1384.
Reich, R., Royce, L., and Martin, G.R. (1989)Biochem. Biophys. Res. Commun. 160, 559–564.
Maione, T., Gray, G., Petro, J., Hunt, A., Donner, A., Bauer, S., Carson, H., and Sharpe, R. (1990)Science 247, 77–79.